Riding Big Pharma's open data wave, J&J taps Yale to manage requests

J&J is jumping in line behind its Big Pharma peers, opening its vault of clinical trial data to the public. To do so, it's enlisting Yale University, which will provide an independent body to assess data requests and make the final calls on who sees what. More

Suggested Articles

Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won.

While the FDA gave an emergency green light to chloroquine's use against coronavirus, European regulators are restricting the drug to clinical trials.

Biocon has finally satisfied the FDA that its insulin production plant in Malaysia is ready for prime time.